Bajaj Healthcare Surges 7% on Stellar Q3 Profit Growth, Revenue Jumps 31%

HEALTHCAREBIOTECH

Overview

Bajaj Healthcare shares leaped 7.3% after the company reported a 33.7% year-on-year surge in net profit to ₹15.67 crore for Q3FY26. Revenue climbed 31.3% to ₹161.22 crore, driven by strong domestic and export performance. The company also launched a new CNS product.

Q3 Financial Performance

Bajaj Healthcare shares surged on Friday after the company announced robust financial results for the December quarter. Net profit rose a significant 33.7% year-on-year to ₹15.67 crore. This jump was fueled by a strong 31.3% increase in revenue from operations, which reached ₹161.22 crore.

Earnings before interest, tax, depreciation, and amortisation (Ebitda) also saw healthy growth, climbing 34.6% to ₹32.33 crore. The Ebitda margin improved slightly to 19.8% from 19.2% in the prior year, indicating improved operational efficiency.

New Product Launch and Strategy

Adding to the positive financial news, Bajaj Healthcare announced the launch of Magnesium L-Threonate (Magtein) in India. This was achieved through a collaboration with Threotech LLC, expanding the company's central nervous system (CNS) portfolio. Management highlighted a strategic shift towards exports, leveraging its active pharmaceutical ingredients (API) foundation and credibility in regulated markets.

Management Outlook

Anil Jain, managing director, expressed confidence in achieving sustainable growth. The company plans to maintain cost competitiveness, secure key international approvals, and invest further in research and development. Continued capital expenditure and management expertise are expected to drive value for stakeholders and the broader healthcare ecosystem.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.